Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Moodys
Dow
Colorcon
Baxter

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR MONTELUKAST SODIUM


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Montelukast Sodium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000577 ↗ Asthma Clinical Research Network (ACRN) Withdrawn National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1993-09-01 This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
NCT00000577 ↗ Asthma Clinical Research Network (ACRN) Withdrawn Milton S. Hershey Medical Center Phase 3 1993-09-01 This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
NCT00076973 ↗ An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272) Completed Merck Sharp & Dohme Corp. Phase 3 2003-08-01 The purpose of this study is to look at whether an investigational drug can treat the breathing symptoms of RSV bronchiolitis in children 3 to 24 months of age.
NCT00092105 ↗ Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) Completed Merck Sharp & Dohme Corp. Phase 3 2002-04-01 The purpose of this study is to determine the protective effect of an approved medication on asthma and allergic rhinitis (inflammation of the mucous membrane of the nose) upon exposure to cats.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Montelukast Sodium

Condition Name

Condition Name for Montelukast Sodium
Intervention Trials
Asthma 35
Healthy 11
Seasonal Allergic Rhinitis 7
Allergic Rhinitis 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Montelukast Sodium
Intervention Trials
Asthma 32
Rhinitis 20
Rhinitis, Allergic 19
Rhinitis, Allergic, Seasonal 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Montelukast Sodium

Trials by Country

Trials by Country for Montelukast Sodium
Location Trials
United States 26
India 12
Poland 5
Korea, Republic of 5
China 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Montelukast Sodium
Location Trials
North Dakota 4
Wisconsin 3
New Jersey 2
Missouri 2
Massachusetts 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Montelukast Sodium

Clinical Trial Phase

Clinical Trial Phase for Montelukast Sodium
Clinical Trial Phase Trials
Phase 4 19
Phase 3 29
Phase 2 7
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Montelukast Sodium
Clinical Trial Phase Trials
Completed 69
Unknown status 5
Withdrawn 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Montelukast Sodium

Sponsor Name

Sponsor Name for Montelukast Sodium
Sponsor Trials
Merck Sharp & Dohme Corp. 35
Dr. Reddy's Laboratories Limited 6
Torrent Pharmaceuticals Limited 4
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Montelukast Sodium
Sponsor Trials
Industry 59
Other 38
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Merck
Boehringer Ingelheim
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.